HeartBeam’s peer-reviewed ECG data raises the stakes in remote cardiac diagnostics
HeartBeam’s ECG evidence could push chest pain assessment closer to patients. The next test is FDA clarity and clinical trust.
HeartBeam’s ECG evidence could push chest pain assessment closer to patients. The next test is FDA clarity and clinical trust.
Monthly PCSK9 therapy is getting crowded. LIB Therapeutics’ LEROCHOL data raise a sharper question on adherence, access and durability.
Oral PCSK9 drugs need more than strong LDL data. Merck’s enlicitide paper tests whether peptide manufacturing can scale.
Tenvie Therapeutics begins Phase 1 dosing of TNV262. Find out why this CNS-penetrant NLRP3 inhibitor could reshape obesity and CVD treatment.